What is the uptake rate for switching from a reference biologic to a biosimilar?

Uptake rates for switching from reference biologics to biosimilars range widely, with influences including drug type, region, and healthcare policies, leading to reported rates from 14.8% to over 80% for different biologics.

Keywords

switching, drug substitution, treatment transition, healthcare, biologics, biopharmaceuticals, biosimilar, uptake rate, pharmacology, reference biologic

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

0

Average